Multimarker Strategy for Heart Failure Prognostication. Value of Neurohormonal Biomarkers: Neprilysin vs NT-proBNP

McMurray, 2012, Eur Heart J., 33, 1787, 10.1093/eurheartj/ehs104 Braunwald, 2008, Biomarkers in heart failure, N Engl J Med., 358, 2148, 10.1056/NEJMra0800239 Lupón, 2014, Development of a novel heart failure risk tool: the Barcelona bio-heart failure risk calculator (BCN bio-HF calculator), PLoS One., 9, e85466, 10.1371/journal.pone.0085466 Pascual-Figal, 2011, Soluble ST2, high-sensitivity troponin T and N-terminal pro-Btype natriuretic peptide: complementary role for risk stratification in acutely decompensated heart failure, Eur J Heart Fail, 13, 718, 10.1093/eurjhf/hfr047 Kenny, 1993, Hydrolysis of human and pig brain natriuretic peptides, urodilatin, C-type natriuretic peptide and some C-receptor ligands by endopeptidase-24.11, Biochem J, 291, 83, 10.1042/bj2910083 Vijayaraghavan, 1990, The hydrolysis of endothelins by neutral endopeptidase 24.11 (enkephalinase), J Biol Chem., 265, 14150, 10.1016/S0021-9258(18)77280-3 Bayés-Genís, 2014, Soluble neprilysin is predictive of cardiovascular death and heart failure hospitalization in heart failure patients, J Am Coll Cardiol., 65, 657, 10.1016/j.jacc.2014.11.048 Bayes-Genis, 2012, Combined use of high-sensitivity ST2 and NTproBNP to improve the prediction of death in heart failure, Eur J Heart Fail., 14, 32, 10.1093/eurjhf/hfr156 Bayes-Genis, 2014, Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST-2 versus galectin-3, J Am Coll Cardiol., 63, 158, 10.1016/j.jacc.2013.07.087 Pencina, 2011, Extensions of net reclassification improvement calculations-measure usefulness of new biomarkers, Stat Med., 30, 11, 10.1002/sim.4085 Yancy, 2013, 2013 ACCF/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, J Am Coll Cardiol., 62, e147, 10.1016/j.jacc.2013.05.019 Oremus, 2014, A systematic review of BNP and NT-proBNP in the management of heart failure: overview and methods, Heart Fail Rev., 19, 413, 10.1007/s10741-014-9440-0 Ahmad, 2012, Novel biomarkers in chronic heart failure, Nat Rev Cardiol., 9, 347, 10.1038/nrcardio.2012.37 McMurray, 2014, Angiotensin-neprilysin inhibition versus enalapril in heart failure, N Engl J Med., 371, 993, 10.1056/NEJMoa1409077 Packer, 2015, Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure, Circulation., 131, 54, 10.1161/CIRCULATIONAHA.114.013748 Oefner, 2000, Structure of human neutral endopeptidase (neprilysin) complexed with phosphoramidon, J Mol Biol., 296, 341, 10.1006/jmbi.1999.3492 Maggioni, 2013, Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12440 patients of the ESC Heart Failure Long-Term Registry, Eur J Heart Fail., 10, 1173, 10.1093/eurjhf/hft134 Zamora, 2014, Long-term prognostic value for patients with chronic heart failure of estimated glomerular filtration rate calculated with the new CKD-EPI equations containing cystatin C, Clin Chem., 60, 481, 10.1373/clinchem.2013.212951 Anwaruddin, 2006, Renal function, congestive heart failure, and amino-terminal pro-brain natriuretic peptide measurement: results from the ProBNP Investigation of Dyspnea in the Emergency Department (PRIDE) Study, J Am Coll Cardiol., 47, 91, 10.1016/j.jacc.2005.08.051 Van Kimmenade, 2009, Renal clearance of B-type natriuretic peptide and amino terminal pro-B-type natriuretic peptide a mechanistic study in hypertensive subjects, J Am Coll Cardiol., 53, 884, 10.1016/j.jacc.2008.11.032 Zamora, 2007, ¿El índice de masa corporal influye en la mortalidad de los pacientes con insuficiencia cardiaca?, Rev Esp Cardiol., 60, 1127, 10.1157/13111784 Puig, 2014, Valor pronóstico del índice de masa corporal y el perímetro de cintura en los pacientes con insuficiencia cardiaca crónica (Registro Español REDINSCOR), Rev Esp Cardiol., 67, 101, 10.1016/j.recesp.2013.06.025 Madamanchi, 2014, Obesity and natriuretic peptides, BNP and NT-proBNP: mechanisms and diagnostic implications for heart failure, Int J Cardiol., 176, 611, 10.1016/j.ijcard.2014.08.007 Bayes-Genis, 2015, Multiple biomarker strategies for risk stratification in heart failure, Clin Chim Acta., 443, 120, 10.1016/j.cca.2014.10.023 Ky, 2012, Multiple biomarkers for risk prediction in chronic heart failure, Circ Heart Fail., 5, 183, 10.1161/CIRCHEARTFAILURE.111.965020 Daniels, 2014, Using ST2 in cardiovascular patients: a review, Future Cardiol., 10, 525, 10.2217/fca.14.36 De Antonio, 2012, Combined use of high-sensitivity cardiac troponin T and N-terminal pro-B type natriuretic peptide improves measurements of performance over established mortality risk factors in chronic heart failure, Am Heart J., 163, 821, 10.1016/j.ahj.2012.03.004 Delgado, 2014, Costes sanitarios y no sanitarios de personas que padecen insuficiencia cardiaca crónica sintomática en España, Rev Esp Cardiol., 67, 643, 10.1016/j.recesp.2013.12.016